VEGFA and hematoma: Other biomarkers such as the brain natriuretic peptide have been investigated as prognostic markers for the long-term functional outcome of cSDH, while vascular endothelial growth factor (VEGF) concentration in cSDH has been investigated as a potential biomarker for hematoma recurrence [6,7,8].